Socioeconomic status and polycystic ovary syndrome

Journal of Women's Health

Volumn 20, Issue 3, 2011, Pages 413-419

  Merkin, Sharon Stein ^a   Azziz, Ricardo ^a,b   Seeman, Teresa ^a   Calderon Margalit, Ronit ^c   Daviglus, Martha ^d   Kiefe, Catarina ^e   Matthews, Karen ^f   Sternfeld, Barbara ^g   Siscovick, David ^h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g KAISER PERMANENTE   (United States)

^h UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EDUCATIONAL STATUS; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATIENT MOBILITY; PRIORITY JOURNAL; RISK; SOCIAL STATUS; WAIST CIRCUMFERENCE;

ADULT; ATTITUDE TO HEALTH; FAMILY RELATIONS; FEMALE; HEALTH STATUS; HEALTH STATUS DISPARITIES; HUMANS; POLYCYSTIC OVARY SYNDROME; POVERTY; PREVALENCE; RISK FACTORS; SOCIAL CLASS; SOCIOECONOMIC FACTORS;

EID: 79952741962     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2010.2303     Document Type: Article

References (46)

1. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreales HF. Prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian wo-men from Spain. J Clin Endocrinol Metab 2000;85:2434-2438. (Pubitemid 32269197)
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile. J Clin Endo-crinol Metab 1999;84:4006-4011. (Pubitemid 30644187)
3. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin En-docrinol Metab 2004;89:2745-2749. (Pubitemid 38766360)
4. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
5. Bermejo EM, Luque-Ramirez M, Escobar-Morreale HF. Obesity and the polycystic ovary syndrome. Min Endocrinol 2007;32:129-140.
6. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005;26:251-282.
7. Goodarzi MO, Erickson S, Port SC, Jennrich RI, Korenman SG Relative impact of insulin resistance and obesity on cardiovascular risk factors in polycystic ovary syndrome. Metabolism 2003;52;713-719. (Pubitemid 36896304)
8. Lo JC, Feigenbaum SL, Yang J, Pressman AR, Selby JV, Go AS. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:1357-1363.
9. Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 2006;29:270-280.
10. Orio F, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: An ob-servational, analytical, prospective case-control study. J Clin Endocrinol Metab 2004;89:3696-3701. (Pubitemid 39071458)
11. Graham H, Der G Influences on women's smoking status: The contribution of socioeconomic status in adolescence and adulthood. Eur J Public Health 1999;9:137-141. (Pubitemid 29274781)
12. Barkley GS. Factors influencing health behaviors in the National Health and Nutritional Examination Survey III (NAHNES III). Soc Work Health Care 2008;46:57-79.
13. Thurston RC, Kubzansky LD, Kawachi I, Berkman LF. Is the association between socioeconomic position and coronary heart disease stronger in women than in men? Am J Epi-demiol 2005;162:57-65. (Pubitemid 40885001)
14. Martorell R, Khan LK, Hughes ML, Grummer-Strawn LM. Obesity in women from developing countries. Eur J Clin Nutr 2000;54:247-252. (Pubitemid 30156736)
15. Cupisti S, Häberle L, Dittrich R, et al. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggra-vated insulin resistance. Fertil Steril2010;94:673-677.
16. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;352:1223-1236.
17. Marmot MG, Smith GD, Stansfeld S, et al. Health inequal-ities among British civil servants: The Whitehall II Study. Lancet 1991;337:1387-1393.
18. Lynch J, Kaplan GA, Salonen R, Cohen RD, Salonen J. So-cioeconomic status and carotid atherosclerosis. Circulation 1995;92:1786-1792.
19. Gonzalez MA, Artalejo FR, Calero JDR. Relationship be-tween socioeconomic status and ischaemic heart disease in cohort and case-control studies: 1960-1993. Int J Epidemiol 1998;27:350-358.
20. Diez-Roux AV, Nieto FJ, Tyroler HA, Crum LD, Szklo M. Social inequalities in atherosclerosis. Am J Epidemiol 1995; 141:960-972.
21. Brunner EJ, Marmot MG, Nanchahal K, et al. Social in-equality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II Study. Diabeto-logica 1997;40:1341-1349. (Pubitemid 27469676)
22. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-1116. (Pubitemid 19039041)
23. Pearlman WH, Crepy O, Murphy M. Testosterone-binding levels in the serum of women during the normal menstrual cycle, pregnancy, and the post-partum period. J Clin En-docrinol Metab 1967;27:1012-1018.
24. Winkelby MA, Jatulis DE, Frank E, Fortmann SP. Socio-economic status and health: How education, income, and occupation contribute to risk factors for cardiovascular dis-ease. Am J Public Health 1992;82:816-820
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treat-ment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001. 285. 2486-2497.
26. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific Publications, 1992: 377-384.
27. Norman RJ, Masters SC, Hague W, Beng C, Pannall P, Wang JX. Metabolic approaches to the subclassification of poly-cystic ovary syndrome. Fertil Steril 1995;63:329-335.
28. Majumdar A, Singh TA. Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome. J Hum Reprod Sci 2009;2:12-17.
29. Senese LC, Almeida ND, Fath AK, Smith BT, Loucks EB. Associations between childhood socioeconomic position and adulthood obesity. Epidemiol Rev 2009;31:21-51. [Epub ahead of print]
30. Lawlor DA, Ebrahim S, Davey Smith G Socioeconomic position in childhood and adulthood and insulin resistance: Cross-sectional survey using data from British Women's Heart and Health Study. BMJ 2002;325:805.
31. Eriksson JG, Forsen TJ, Osmond C, Barker DJ. Pathways of infant and childhood growth that lead to type 2 diabetes. Diabetes Care 2003;26:3006-3010. (Pubitemid 37339490)
32. Davey Smith G, Hart C Insulin resistance syndrome and childhood social conditions. Lancet 1997;349:284-285.
33. Lawlor DA, Smith GD, Ebrahim S. Association between childhood socioeconomic status and coronary heart disease risk among postmenopausal women: Findings from the British Women's Heart and Health Study. Am J Public Health 2004;94:1386-1392. (Pubitemid 39006814)
34. Wannanethee SG, Whincup PH, Shaper G, Walker M. In-fluence of fathers' social class on cardiovascular disease in middle-aged men. Lancet 1996;348:1259-1263. (Pubitemid 26377236)
35. Ekelund U, Ong KK, Linné Y, et al. Association of weight gain in infancy and early childhood with metabolic risk in young adults. J Clin Endocrinol Metab 2007;92:98-103. (Pubitemid 46067515)
36. Gardner DSL, Hosking J, Metcalf BS, Jeffrey AN, Voss LD, Wilkin TJ. Contribution of early weight gain to childhood overweight and metabolic health: A longitudinal study (Early Bird 36). Pediatrics 2009;123:e67-e73.
37. Xita N, Tsatsoulis A. Review: Fetal programming of poly-cystic ovary syndrome by androgen excess: Evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006;91:1660-1666.
38. Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf) 2006;65: 137-145. (Pubitemid 44079674)
39. Carmina E. Genetic and environmental aspect of polycystic ovary syndrome. J Endocrinol Invest 2003;26:1151-1159. (Pubitemid 38195457)
40. Hickey TE, Legro RS, Norman RJ. Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:2789-2791. (Pubitemid 44024652)
41. Harlow SD, Matanoski GM. The association between weight, physical activity and stress and variation in the length of the menstrual cycle. Am J Epidemiol1991;133:38-49.
42. Gillum RF, Paffenbarger RS Jr. Chronic disease in former college students. XVII. Sociocultural mobility as a precursor of coronary heart disease and hypertension. Am J Epidemiol 1978;108:289-298. (Pubitemid 9154527)
43. Rosvall M, Chaix B, Lynch J, Lindström M, Merlo J. Similar support for three different life course socioeconomic models on predicting premature cardiovascular mortality and all-cause mortality. BMC Public Health 2006;6:203.
44. Bean JA, Leeper JD, Wallace RB, Sherman BM, Jagger H. Variations in the reporting of menstrual histories. Am J Epidemiol 1979;109:181-185. (Pubitemid 10201149)
45. Smith-DiJulio K, Mitchell ES, Woods NF. Concordance of retrospective and prospective reporting of menstrual irreg-ularity by women in the menopausal transition. Climacteric 2005;8:390-397 (Pubitemid 41617488)
46. Souter I, Sanchez LA, Perez M, Bartolucci AA, Azziz R. The prevalence of androgen excess among patients with minimal unwanted hair growth. Am J Obstet Gynecol 2004;191:1914-1920. (Pubitemid 39601494)